BioArctic AB

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Regeneron Bolsters Ophthalmic Portfoli

The Nordic region is punching well above its weight in terms of pipeline size, numbers of companies and clinical trials as well as fundraising activities, and the future for firms in Iceland, Finland

Mitsubishi Tanabe Pharma Corporation ’s billion-dollar bid nearly six years ago for NeuroDerm Ltd. and its drug for Parkinson’s disease looks likely to pay off as the Israeli drug developer announced

Just a couple of months after BioArctic AB trumpeted partner AbbVie Inc. 's plans to advance their Parkinson's drug ABBV-0805 into mid-stage trials this year, the US major has pulled the plug on a